9/28/23: Opioid Use Disorder Treatment Integrated with Primary Care-MOUD 2-hr Training Slide Set

MOUD 2-hr Training Slide Set

Pdf Summary

Dr. Michael Fingerhood from Johns Hopkins University discusses the integration of opioid use disorder (OUD) treatment with primary care. He emphasizes the importance of treating OUD as a chronic medical condition and addresses the need for integrated care to improve patient outcomes. The learning objectives of his presentation include reviewing the medications for OUD, describing the process of buprenorphine initiation and maintenance, discussing harm reduction strategies, and reviewing the steps for completing the online waiver application to prescribe buprenorphine.<br /><br />Dr. Fingerhood highlights the benefits of integrating substance use disorder treatment with primary care, including improved coordination of care, better outcomes, and increased patient satisfaction. He emphasizes the importance of establishing trust and rapport with patients and provides guidelines for taking patient history and evaluation.<br /><br />He also addresses common reasons for prescribing buprenorphine, such as managing opioid withdrawal, covering for a provider who has a patient on buprenorphine, and helping patients with chronic pain who inquire about switching to buprenorphine. He emphasizes the benefits of medication-assisted treatment (MAT), including reduced risk of overdose and fewer drug interactions.<br /><br />Dr. Fingerhood discusses the different medications used for OUD, including methadone, buprenorphine, and naltrexone. He provides information on the initiation, dosing, safety, and side effects of each medication. He also discusses the importance of monitoring patients' adherence to treatment and recommends using urine toxicology testing and prescription drug monitoring programs.<br /><br />Lastly, Dr. Fingerhood emphasizes the importance of harm reduction strategies, including naloxone distribution, safe injection practice counseling, and overdose education. He also addresses the importance of using person-first language and avoiding stigmatizing terms when discussing addiction.<br /><br />In summary, Dr. Fingerhood's presentation provides valuable information on the integration of OUD treatment with primary care, the medications used for OUD, and the importance of harm reduction and person-centered care.

Keywords

OUD treatment

integrated care

medications for OUD

buprenorphine initiation

harm reduction strategies

online waiver application

patient outcomes

methadone

naltrexone

person-centered care